Metformin ER
Sponsors
Laboratorios Silanes S.A. de C.V., Massachusetts General Hospital, M.D. Anderson Cancer Center, Boehringer Ingelheim, Matthew Neal MD
Conditions
AgingColorectal CarcinomaColorectumHealthyIntermittent ClaudicationPolycystic Ovary SyndromePreeclampsia
Phase 1
Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)
CompletedNCT00941239
Start: 2007-01-31End: 2007-02-28Updated: 2018-01-30
An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin
TerminatedNCT01816659
Start: 2013-05-31End: 2014-08-31Updated: 2015-11-18
Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects
CompletedNCT02084082
Start: 2014-04-30End: 2014-07-31Updated: 2016-08-04
Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects
CompletedNCT02121509
Start: 2014-05-31End: 2014-07-31Updated: 2016-08-04
Phase 3
REMAP Trial for Optimizing Surgical Outcomes at UPMC
TerminatedNCT03861767
Start: 2019-04-15End: 2022-09-23Updated: 2024-06-18
MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
RecruitingNCT05132439
Start: 2022-03-01End: 2032-02-28Target: 200Updated: 2026-04-21
PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia
RecruitingNCT06033131
Start: 2024-01-19End: 2029-12-31Target: 294Updated: 2026-08-07
Unknown Phase
Polycystic Ovary Syndrome Genetics and Treatment Response
NCT01389778
Start: 2011-06-30End: 2019-10-31Target: 200Updated: 2018-08-16
Prospective Trial of Metformin - Chemoprevention Role
WithdrawnNCT01550900
Start: 2013-07-31Updated: 2013-04-05
Metformin Treatment in Polycystic Ovary Syndrome (PCOS)
NCT02198417
Start: 2014-07-31End: 2020-12-31Target: 20Updated: 2018-08-16